Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Muscle Dysmorphia ('Bigorexia')

The body-image disorder driving androgen and supplement use

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not applicable (clinical condition)

Reference only. Not medical advice.

What can go wrong

Compulsive exercise, disordered eating, impaired functioning, depression, and progression to anabolic-steroid use. The condition is reinforced by fitness/physique social media.

This is something to take to a clinician. The Atlas can tell you what is known about muscle dysmorphia ('bigorexia') in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Muscle dysmorphia (colloquially 'bigorexia') is a recognized subtype of body dysmorphic disorder in which a man is preoccupied with being insufficiently muscular, despite often being visibly large. Described by Pope and colleagues (who called an early version the 'Adonis complex'), it drives compulsive training, dietary rigidity, social and occupational impairment, and is a significant risk factor for anabolic-steroid use. It sits at the intersection of male body image, the optimization industry, and PED use, and is under-recognized because the sufferer looks healthy or enviable.

The flip side of anorexia, never big enough, and a driver of steroid use.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Documents the psychology behind compulsive enhancement

What people get wrong

  • Often saidWanting to be more muscular is just discipline

    ActuallyAt the clinical end it is a body-image disorder with the same machinery as anorexia, causing real impairment and driving high-risk drug use, not mere motivation.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Classification
Subtype of body dysmorphic disorder (DSM-5)
Coined
Pope et al. ('Adonis complex')
Link
Major risk factor for AAS use

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Muscle Dysmorphia ('Bigorexia'). A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Pope et al.1997-2000

    Characterized muscle dysmorphia / the 'Adonis complex' as a BDD subtype linked to AAS use